 HIGHLANDS RANCH, Colo., April 14, 2021 GLOBE NEWSWIRE -- Vivos Therapeutics, Inc. the Company NASDAQ: VVOS, a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea OSA, today announced the appointment of Mimi Guarneri, MD, FACC as an independent consultant serving in the role of Medical Director of Clinical Education, effective April 1, 2021. 